From 2013 to 2023, the Swedish veterinary vaccines market, excluding Foot and Mouth disease vaccines, expanded significantly, reaching 68.379 million USD in 2023. The Compound Annual Growth Rate (CAGR) over the past five years was 2.46%, showcasing steady increase, albeit at a slower pace compared to the previous decade. Notable growth occurred from 2016 to 2017 driven by a surge in adoption, while recent years saw more modest growth rates.
Future trends suggest potential growth in the market, driven by:
- Advancements in vaccine technology.
- Increased investment in animal health.
- Rising awareness of animal welfare and disease prevention.
